Biomerica: Down after revenue falls, loss widens
** Shares of biomedical co BMRA.O fall ~5% to $5.76
** Co's Q2 FY21 worldwide revenue falls to $1.4 mln from
$1.6 mln due to lower sales in Asia urn:newsml:reuters.com:*:nGNX23zQgJ
** BMRA's Q2 net loss widens to $1.5 mln from net loss of
$0.5 mln a year earlier
** Increase in net loss was primarily due to higher research
and development expense and higher general and administrative
expenses - BMRA
(Reporting by Shreyasee Raj in Bengaluru)
((Shreyasee.Raj@thomsonreuters.com;))
Recent news on Biomerica
See all newsDiagnostics firm Biomerica's Q1 revenue drops on lower clinical lab orders
Brief: Biomerica May Offer Up To $250 Million Of Common Stock, Preferred Stock, Debt Securities, & Warrants
Brief: Biomerica Lands $1.75 Million CDMO Master Services Agreement For IVD Diagnostic Development
Biomerica's Q3 revenue falls, net loss widens on lower manufacturing sales
Brief: Biomerica Q3 Net Income USD -1.31 Million